Conceptual Framework for SARS-CoV-2-Related Lymphopenia

Area of Science:

• Immunology
• Virology
• Pathophysiology

Background:

• The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic presents significant global health challenges.
• Lymphopenia is a distinct characteristic of coronavirus disease-19 (COVID-19), contrasting with other viral infections.

Purpose of the Study:

• To investigate the immunological mechanisms underlying lymphopenia in COVID-19 patients.
• To explore the roles of innate and adaptive immune responses in SARS-CoV-2 infection-induced lymphopenia.

Main Methods:

• Review and synthesis of current research on immune responses during SARS-CoV-2 infection.
• Analysis of proposed molecular pathways, including nicotinamide adenine dinucleotide (NAD)+ metabolism and T cell dynamics.

Main Results:

• SARS-CoV-2 infection leads to hyperactivation of poly-ADP-ribose polymerase, causing NAD+ and ATP depletion, and cell death.
• A sharp decline in cytotoxic T lymphocytes is observed, potentially due to sequestration in the lower respiratory tract.
• Factors like CD38 activity, cytokine storm-induced lung sequestration, and viral protein 7a-mediated apoptosis contribute to lymphopenia.

Conclusions:

• Multiple mechanisms contribute to lymphopenia in COVID-19, involving both innate and adaptive immune dysregulation.
• Further research is required to fully elucidate the complex pathways driving lymphopenia in SARS-CoV-2 infection.